Gambia vs Kenya: Cause of death, by non-communicable diseases, ages 15-59, female
Gambia
38.3%
in 2021
Kenya
39.8%
in 2021
Gambia rank
167th
Kenya rank
165th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Gambia
- Kenya
How they compare
Kenya currently reports 39.8% against 38.3% in Gambia, a difference of 1.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Gambia ahead.
Gambia ranks 167th and Kenya ranks 165th of 185 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Kenya in 2.
Head to head by decade
| Decade | Gambia | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.9% | 11.0% | 18.9% | Gambia |
| 2010s | 35.7% | 38.0% | 2.2% | Kenya |
| 2020s | 38.9% | 41.9% | 3.1% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Gambia or Kenya?
- Kenya, at 39.8% against 38.3% in Gambia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Gambia and Kenya?
- 1.5%, with Kenya ahead.
- How many years of comparable data are there for Gambia and Kenya?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Kenya rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Gambia ranks 167th and Kenya ranks 165th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.